Response variability to clopidogrel: is tailored treatment, based on laboratory testing, the right solution?
Exogenous activated protein C inhibits the progression of diabetic nephropathy
Is atrial fibrillation associated with pulmonary embolism?
Prospective study of seasonal patterns in hemostatic factors in older men and their relation to excess winter coronary heart disease deaths
A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management
Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti-factor Xa levels
European and American suspected and confirmed pulmonary embolism populations: comparison and analysis
Correlation of factor IXa subsite modulations with effects on substrate discrimination
Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide-based enzyme capture assay
Plasma-derived human antithrombin attenuates ventilator-induced coagulopathy but not inflammation in a Streptococcus pneumoniae pneumonia model in rats
Prohibitins are involved in protease-activated receptor 1-mediated platelet aggregation
Defective diacylglycerol-induced Ca2+entry but normal agonist-induced activation responses in TRPC6-deficient mouse platelets
Binding of heparin-dependent antibodies to PF4 modified by enoxaparin oligosaccharides: evaluation by surface plasmon resonance and serotonin release assay
Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol
In vivo monitoring of venous thrombosis in mice
ATP-gated P2X1 ion channels protect against endotoxemia by dampening neutrophil activation
Early onset of endothelial cell proliferation in coronary thrombi of patients with an acute myocardial infarction: implications for plaque healing
Sensitivity of whole blood clotting time and activated partial thromboplastin time for factor IX: relevance to gene therapy and determination of post-transfusion elimination time of canine factor IX in hemophilia B dogs
Definition of post-thrombotic syndrome following lower extremity deep venous thrombosis and standardization of outcome measurement in pediatric clinical investigations
Solicited self-referencing undermines the credibility of researchers and journals
The Northwick Park Heart Studies: contrasts between the two factor VII assays used
Podoplanin-expressing inflammatory macrophages activate murine platelets via CLEC-2
High on-treatment platelet reactivity assessed by various platelet function tests: is the consensus-defined cut-off of VASP-P platelet reactivity index too low?
A NOD/SCID mouse model for the assessment of human platelet aggregation in vivo
Enhancing factor VIII and VIIIa stability by combining mutations at the A2 domain interface and A1–C2 domain interface
Difference in interpretation of computed tomography pulmonary angiography diagnosis of subsegmental thrombosis in patients with suspected pulmonary embolism
Heparin promotes soluble vascular enothelial growth factor receptor expression in human placental villi: a rebuttal
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: a rebuttal
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: reply to a rebuttal